comparemela.com

Latest Breaking News On - Leukemia at memorial sloan kettering cancer center - Page 1 : comparemela.com

Oncolyze Launches an Equity Crowdfunding Campaign on StartEngine

Oncolyze Logo Oncolyze Logo NEW YORK, March 23, 2023 (Newswire.com) - Oncolyze has launched a Regulation A+ ("Reg A") funding campaign to spread awareness of OM-301 among cancer patients, healthcare professionals, and the investment community. Reg A is a type o.

Mika stojanovicAlex stojanovicSteven evansPostdoctoral fellow at northwestern universityStartengine primaryOffice of orphan drug productsYork university school of medicineLeukemia at memorial sloan kettering cancer centerExchange commissionDartmouth collegeLeukemia at city of hope medical centerDrug designationOrphan drug productsNew york university schoolCardiovascular diseaseMemorial sloan kettering cancer center

Oncolyze, a Company Aiming to Treat Cancer by Exploding

NEW YORK, Aug. 23, 2022 (GLOBE NEWSWIRE) After successfully completing in vitro and in vivo (mice) experiments, which support the notion that its lead.

Alex stojanovicMika stojanovicSteven evansDartmouth collegeOffice of orphan drug productsLeukemia at memorial sloan kettering cancer centerExchange commission under tierLeukemia at city of hope medical centerExchange commissionYork university school of medicinePostdoctoral fellow at northwestern universityOrphan drugOrphan drug productsNew york university schoolCardiovascular diseaseMemorial sloan kettering cancer center

vimarsana © 2020. All Rights Reserved.